The First Affiliated Hospital with Nanjing Medical University
Phase
Observational
Started
2024-03-01
Last updated
2024-04-10
Condition(s) studied
Hepatocellular CarcinomaImmunotherapy
Investigational drug(s) / intervention(s)
Immunotherapy-based Combination Therapies
Immunotherapy-based Combination Therapies: immunotherapy-based combination therapies in Chinese HCC patients within the practical context of real-world conditions
Study summary
This study is an observational real-world research conducted on Chinese hepatocellular carcinoma (HCC) patients. Its primary objective is to evaluate the safety and efficacy of immunotherapy-based combination therapies in Chinese HCC patients within the practical context of real-world conditions.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Aged after 18 years (18 is included).
2. Hepatocellular carcinoma diagnosed by pathology or imaging.
3. Patients assessed by researchers as potentially benefiting from receiving immunotherapy-based combination regimens.
4. For participants who have previously received treatment according to this protocol, a comprehensive pre-treatment assessment is required, including demographic information, tumor history, medical history, and baseline imaging examinations.
5. Patients voluntarily enroll in this study.
Exclusion Criteria:
1. Pregnant or lactating women.
2. Other conditions regimented at investigators' discretion.
Primary outcome measure(s)
Adverse events — 24 months All adverse events during the course of the study treatment.
Trial sites (1)
Facility
City
Region
Status
Jiangsu Province Hospital
Nanjing
Jiangsu
Recruiting
More The First Affiliated Hospital with Nanjing Medical University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.